loadpatents
name:-0.019268989562988
name:-0.0085258483886719
name:-0.0037069320678711
Mellis; Scott Patent Filings

Mellis; Scott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mellis; Scott.The latest application filed is for "treatment of fibrodysplasia ossificans progressiva".

Company Profile
2.8.15
  • Mellis; Scott - New Rochelle NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Of Fibrodysplasia Ossificans Progressiva
App 20210253685 - Economides; Aristides ;   et al.
2021-08-19
Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations
App 20190330371 - SWERGOLD; Gary ;   et al.
2019-10-31
Methods For Treating Autosomal Dominant Hypercholesterolemia Associated With Pcsk9 Gain-of-function Mutations
App 20140356370 - SWERGOLD; Gary ;   et al.
2014-12-04
Methods of using IL-1 antagonists to treat autoinflammatory disease
Grant 8,414,876 - Mellis , et al. April 9, 2
2013-04-09
Use Of Il-1 Antagonists To Treat Pseudogout
App 20120114645 - Vicary; Catherine ;   et al.
2012-05-10
Use of IL-1 antagonists to treat gout
Grant 8,114,394 - Vicary , et al. February 14, 2
2012-02-14
Methods Of Using Il-1 Antagonists To Treat Autoinflammatory Disease
App 20110318342 - Mellis; Scott ;   et al.
2011-12-29
Methods Of Using Il-1 Antagonists To Treat Familial Mediterranean Fever (fmf)
App 20110311537 - MELLIS; SCOTT ;   et al.
2011-12-22
Use of IL-1 Antagonists to Treat Gout
App 20110008374 - Vicary; Catherine ;   et al.
2011-01-13
Use of IL-1 antagonists to treat gout
Grant 7,820,154 - Vicary , et al. October 26, 2
2010-10-26
Use of IL-1 Antagonists to Treat Gout
App 20100111921 - Vicary; Catherine ;   et al.
2010-05-06
Use of IL-1 antagonists to treat gout
Grant 7,632,490 - Vicary , et al. December 15, 2
2009-12-15
Methods of Using IL-1 Antagonists to Treat Autoinflammatory Disease
App 20090156492 - Mellis; Scott ;   et al.
2009-06-18
Use of IL-1 Antagonists to Treat Gout
App 20090123446 - Vicary; Catherine ;   et al.
2009-05-14
Use of IL-1 antagonists to treat gout and pseudogout
App 20080300185 - Vicary; Catherine ;   et al.
2008-12-04
Methods of using IL-1 antagonists to treat autoinflammatory disease
Grant 7,459,426 - Mellis , et al. December 2, 2
2008-12-02
Use of an IL-1 antagonist for treating arthritis
Grant 7,361,350 - Mellis , et al. April 22, 2
2008-04-22
Methods for identifying a candidate for treatment of obesity
Grant 7,279,282 - Mellis October 9, 2
2007-10-09
Methods of using IL-1 antagonists to reduce C-reactive protein
App 20060171948 - Weinstein; Steven P. ;   et al.
2006-08-03
Methods for identifying a candidate for treatment of obesity
App 20060008832 - Mellis; Scott
2006-01-12
Methods of using IL-1 antagonists to treat autoinflammatory disease
App 20050272655 - Mellis, Scott ;   et al.
2005-12-08
Use of an IL-1 antagonist for treating arthritis
App 20050197293 - Mellis, Scott ;   et al.
2005-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed